Sarepta Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) announced participation in three virtual investor conferences. Senior management will engage in fireside chats at:

• Credit Suisse 30th Annual Healthcare Conference on November 9, 2021 at 12:10 p.m. E.T.
• Barclays Gene Editing & Gene Therapy Summit on November 15, 2021 at 3:00 p.m. E.T.
• Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021 at 1:25 p.m. E.T.

Webcasts will be available on Sarepta’s website, archived for 90 days. The company focuses on precision genetic medicine for rare diseases.

CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at three upcoming virtual investor conferences:

• Credit Suisse 30^th Annual Healthcare Conference on Tuesday, November 9, 2021 at 12:10 p.m. E.T.
• Barclays Gene Editing & Gene Therapy Summit 2021 on Monday, November 15, 2021 at 3:00 p.m. E.T.
• Evercore ISI 4^th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 1:25 p.m. E.T.
  

The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

What is Sarepta Therapeutics announcing on November 2, 2021?

Sarepta Therapeutics announced participation in three upcoming virtual investor conferences.

When will Sarepta present at the Credit Suisse Conference?

Sarepta will present at the Credit Suisse 30th Annual Healthcare Conference on November 9, 2021, at 12:10 p.m. E.T.

What date is the Barclays Gene Editing & Gene Therapy Summit?

The Barclays Gene Editing & Gene Therapy Summit will take place on November 15, 2021, at 3:00 p.m. E.T.

What is the purpose of Sarepta's upcoming presentations?

The presentations aim to engage investors and provide insights into the company's advancements in precision genetic medicine.

How can I access the webcasts of Sarepta's presentations?

Webcasts will be available live on Sarepta's website and archived for 90 days after the presentations.

What is the focus of Sarepta Therapeutics' research?

Sarepta focuses on precision genetic medicine for rare diseases, particularly Duchenne muscular dystrophy and limb-girdle muscular dystrophies.